Vol. 282, Issue 6, E1222-E1230, June 2002
Isotopomer spectral analysis of intermediates of cholesterol
synthesis in human subjects and hepatic cells
B.
Lindenthal1,2,
T. A.
Aldaghlas1,
A. L.
Holleran1,
T.
Sudhop2,
H. K.
Berthold2,
K.
von Bergmann2, and
J. K.
Kelleher1
1 Department of Physiology, The George Washington University
School of Medical and Health Sciences, Washington, District of
Columbia 20037; and 2 Department of Clinical Pharmacology,
University of Bonn, 53105 Bonn, Germany
Steroid intermediates of the
cholesterol synthesis pathway are characterized by rapid turnover rates
relative to cholesterol due to their small pool size. Because the small
pools will label rapidly, these intermediates may provide valuable
information about the incorporation of isotopes in de novo synthesis of
cholesterol and related compounds. The labeling of cholesterol
synthesis intermediates from [1-13C]acetate was
investigated in human subjects and in liver cell models by means of
isotopomer spectral analysis (ISA). In human subjects, infusing
[1-13C]acetate into the duodenum for 12 h
demonstrated that ~50% of the plasma lathosterol pool was derived
from de novo synthesis during this interval. The lipogenic acetyl-CoA
precursor pool enrichment reached a constant value within 3 h of
the start of the infusion. In vitro studies indicated that liver cell
models decrease de novo lathosterol synthesis when cholesterol
synthesis is inhibited by statins or cholesterol-containing serum. We
propose a new calculation to increase the accuracy and precision of
cholesterol synthesis estimates in vivo combining the ISA of
lathosterol and cholesterol.
lathosterol; lanosterol; desmosterol 13C; tracers; theoretical models; experimental models; simvastatin; pravastatin; stable isotopes